Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects
Clinical trial NCT05249374 · COMPLETED
Trial details
- NCT number
- NCT05249374
- Sponsor
- Protgen Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-14
- Primary completion
- 2022-05-16
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.